These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 333871)

  • 1. [Neurochemical aspects and pharmacological implications in essential tremor (preliminary note)].
    Piccoli F; Smorto MP; Raimondo D; Fierro B; Vinci GG; Lupo I; Pastore L; Daniele O
    Acta Neurol (Napoli); 1977; 32(4):473-80. PubMed ID: 333871
    [No Abstract]   [Full Text] [Related]  

  • 2. Proceedings: gamma-Aminobutyric acid metabolism and the anticonvulsant action of ethanolamine-o-sulphate and di-n-propylacetate.
    Anlezark GM; Horton RW; Meldrum BS; Sawaya MC; Stephenson JD
    Br J Pharmacol; 1976 Mar; 56(3):383P-384P. PubMed ID: 769882
    [No Abstract]   [Full Text] [Related]  

  • 3. [The use of sodium dipropylacetate in the treatment of parkinsonian tremor. Preliminary note].
    Piccinin GL; Morocutti C; Urciuoli R; Bernardi G
    Clin Ter; 1977 Jul; 82(1):25-30. PubMed ID: 332440
    [No Abstract]   [Full Text] [Related]  

  • 4. Amantadine and a fixed combination of carbidopa and levodopa in parkinsonism: a preliminary report.
    Savery F
    Curr Ther Res Clin Exp; 1976 Mar; 19(3):337-8. PubMed ID: 817863
    [No Abstract]   [Full Text] [Related]  

  • 5. Time course of the increase in GABA level in different mice brain regions following N-dipropylacetate treatment.
    Simler S; Gensburger C; Ciesielski L; Mandel P
    Commun Psychopharmacol; 1978; 2(2):123-30. PubMed ID: 352606
    [No Abstract]   [Full Text] [Related]  

  • 6. Sodium valproate in chorea.
    Br Med J; 1976 Dec; 2(6051):1562. PubMed ID: 137765
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of Parkinson's syndromes by a combination of levodopa with decarboxylase inhibitors].
    Hanzal F
    Cesk Neurol Neurochir; 1975 Dec; 38(6):327-32. PubMed ID: 1192544
    [No Abstract]   [Full Text] [Related]  

  • 8. [Carbiodopa-levodopa therapy (Sinemet) in the treatment of parkinsonian patients. Results of 4 years of treatment].
    Martínez-Lage JM; Burguera JA; Deldago G; Zubieta JL
    Arch Neurobiol (Madr); 1978; 41(1):3-18. PubMed ID: 697513
    [No Abstract]   [Full Text] [Related]  

  • 9. The long-term effects of combining carbidopa with levodopa for Parkinson's disease.
    Lee MC; Lippert DM; Loewenson RB; Tolosa ES; Resch JA; Martin WE
    Trans Am Neurol Assoc; 1976; 101():262-4. PubMed ID: 829295
    [No Abstract]   [Full Text] [Related]  

  • 10. [Neurochemical aspects of Parkinson tremor].
    Agostini L; Firenze C; Gallai V; Piccinin GL; Piccirilli M; Rossi A
    Clin Ter; 1979 Apr; 89(2):119-25. PubMed ID: 487712
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of Parkinson's disease with levodopa and a dopa decarboxylase inhibitor].
    Londoõ R
    Neurol Neurocir Psiquiatr; 1976; 17(4):293-300. PubMed ID: 1018729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium valproate in chorea.
    Lenman JA; Ferguson IT; Fleming AM; Herzberg M; Robb JE; Turnbull MJ
    Br Med J; 1976 Nov; 2(6044):1107-8. PubMed ID: 136287
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of Parkinson's syndrome with a combination of levodopa and carbidopa].
    Lombardo L; De la Garza R
    Arch Invest Med (Mex); 1977; 8(2):123-8. PubMed ID: 907417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A syndrome from a possible GABA deficiency. Clinical-therapeutic report on 15 cases.
    Cocchi R
    Acta Psychiatr Belg; 1978; 78(2):407-24. PubMed ID: 354328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of studies on the treatment of parkinsonian syndromes with levodopa. II. Long-term effects of L-DOPA alone or in combination with a decarboxylase inhibitor].
    Rabadeau Dumas JL; Rondot P; Cardon P
    Therapie; 1977; 32(2):161-72. PubMed ID: 898124
    [No Abstract]   [Full Text] [Related]  

  • 16. [Proposal for the introduction of a new substance into hospital practice: dipropyl acetate sodium in the prevention and treatment of alcoholic delirium].
    Bonfiglio G; Falli S; Pacini A
    Minerva Med; 1977 Dec; 68(63):4233-45. PubMed ID: 340985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of increased brain gamma-aminobutyric acid levels to influence amphetamine-induced stereotyped behavior.
    Patel BC; Crosset P; Klawans HL
    Res Commun Chem Pathol Pharmacol; 1975 Dec; 12(4):635-43. PubMed ID: 766131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkinson's disease improvement after the addition of levodopa-carbidopa to anticholinergic treatment. An open controlled study.
    Agnoli A; Ruggieri S; Denaro A; Lelli A
    Acta Neurol (Napoli); 1978 Oct; 33(5):436-42. PubMed ID: 756675
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of patients with vascular parkinsonism with the preparations nakom and madopar].
    Kamenetskiĭ VK
    Klin Med (Mosk); 1984 Apr; 62(4):112-6. PubMed ID: 6737958
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapy of rigidity and hypokinesis in old age using Sinemet].
    Drobný M; Adamkov J; Svaleková A; Fundárek J
    Cesk Neurol Neurochir; 1979 May; 42(3):195-204. PubMed ID: 455524
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.